Julie B. Feder, Chief Financial Officer at Aura Biosciences, Inc. (AURA), sold 50,262 shares at $12.03 ($605K) on 2024-10-18, disclosed to the SEC on 2024-10-21.
Scheduled sale ($605k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.03 | 25,131 | $302K | 50.0% |
| 2 | $12.03 | 25,131 | $302K | 50.0% |
| Total | $12.03 avg | 50,262 | $605K | 100% |
| Filing → |
| AURA | SELL | 2023-11-01 | $23K | — | Filing → |
| AURA | SELL | 2022-11-02 | $25K | — | Filing → |